Millennium Management’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Millennium Management’s Portfolio PBE Stock Details PBE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-4,050	Closed	-$205K	–	3563
2015 Q4	$205K	Buy	+4,050	New	+$200K	﹤0.01%	3078
2015 Q3	–	Sell	-4,673	Closed	-$273K	–	3659
2015 Q2	$273K	Sell	4,673 -7,138	-60%	-$408K	﹤0.01%	2924
2015 Q1	$651K	Sell	11,811 -70	-0.6%	-$3.78K	﹤0.01%	2590
2014 Q4	$596K	Buy	+11,881	New	+$581K	﹤0.01%	2868

Other funds holding PBE

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TAM

Trillium Asset Management Boston, Massachusetts $3.01B AUM 19.96% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

TCM

Traynor Capital Management Malvern, Pennsylvania $1.7B AUM 39.15% 1-Year Est. Return

HBT

Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return

CAS

Cue Advisory Services Phoenix, Arizona $167M AUM 18.62% 1-Year Est. Return

Millennium Management's PBE Position: Q1 2016 in Review

Millennium Management sold out of Invesco Biotechnology & Genome ETF (PBE) in Q1 2016, closing a stake of 4,050 shares — an estimated $205K sold.

Millennium Management first reported a position in PBE in Q4 2014 and held it in 4 quarters. The position peaked at $651K in Q1 2015. 71 funds tracked by Wall St. Rank hold PBE as of Q1 2016.

Millennium Management reported no remaining Invesco Biotechnology & Genome ETF position as of Q1 2016 after selling out during the quarter.
Millennium Management sold 4,050 Invesco Biotechnology & Genome ETF shares in Q1 2016, an estimated $205K.
Millennium Management first reported a position in Invesco Biotechnology & Genome ETF in Q4 2014 and held it in 4 quarters.
Millennium Management's Invesco Biotechnology & Genome ETF position peaked at $651K in Q1 2015.
71 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q1 2016.

Based on Millennium Management's 13F filing for Q1 2016, filed 16 May 2016.